N/A
Completed N=326
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
Other Cancer
Source: ClinicalTrials.gov NCT03244826 ↗
Enrolled (actual)
326
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Functional Assessment of Cancer Therapy - Bone Marrow Transplantation (FACT-BMT) at Day 180 — 110.68; 106.89 score on a scale
Summary
This research study aims to evaluate the effectiveness of allowing patients who have had a hematopoietic cell transplant to receive some of their post-transplant care with a local oncologist rather than returning to the transplant center for all of their follow-up.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Functional Assessment of Cancer Therapy - Bone Marrow Transplantation (FACT-BMT) at Day 180 |
110.68; 106.89 | — |
| PRIMARY European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer (EORTC QLQ-C30) at Day 180 |
68.93; 67.01 | — |
| PRIMARY 100-day Non-relapse Mortality (NRM) for Patients in Shared Care Versus Usual Care |
4; 4 | — |
Eligibility Criteria
Inclusion Criteria
- Age >= 18 years of age
- Scheduled to receive an allogeneic HCT at the Dana-Farber Inpatient Hospital or BWH under the care of a DFCI physician
- Residence in New York, Maine, New Hampshire, Vermont, Connecticut, or Massachusetts
- Referred from or live less than 1 hour from one of the local participating centers.
- Ability to read English (to fill out standard QOL forms)
Exclusion Criteria
- Age <18 years of age
- Scheduled to receive an autologous HCT
- Has received an allogeneic transplant in the past; scheduled to receive a second allogeneic transplant
- Did not receive an allogeneic HCT at Dana-Farber
- Does not live in New York, Maine, New Hampshire, Vermont, Connecticut, or Massachusetts
Data sourced from ClinicalTrials.gov (NCT03244826). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.